The study, published in the journal Antioxidants, notes that when mice were given a stable form of carnosic acid, they showed ...

The findings provide new evidence to support the so-called amyloid hypothesis of Alzheimer's disease, which posits that the ...

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

A new study has found that an experimental drug appears to reduce the risk of Alzheimer' s-related dementia in people ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Researchers followed a small group of 22 patients who had genetic mutations that cause the overproduction of amyloid in the ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.